↓ Skip to main content

Dove Medical Press

Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability

Overview of attention for article published in Psoriasis : Targets and Therapy, December 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
facebook
1 Facebook page

Readers on

mendeley
36 Mendeley
Title
Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability
Published in
Psoriasis : Targets and Therapy, December 2016
DOI 10.2147/ptt.s105047
Pubmed ID
Authors

Michael Abrouk, Ethan Levin, Merrick Brodsky, Jessica R Gandy, Mio Nakamura, Tian Hao Zhu, Benjamin Farahnik, John Koo, Tina Bhutani

Abstract

The 308 nm excimer laser is a widely used device throughout the field of dermatology for many diseases including psoriasis. Although the laser has demonstrated clinical efficacy, there is a lack of literature outlining the safety, efficacy, and patient acceptability of the excimer laser. A literature search on PubMed was used with combinations of the terms "excimer", "excimer laser", "308 nm", "psoriasis", "protocol", "safety", "efficacy", acceptability", "side effects", and "dose". The search results were included if they contained information pertaining to excimer laser and psoriasis treatment and description of the safety, efficacy, and patient acceptability of the treatment. The 308 nm excimer laser is generally safe and well tolerated with minimal side effects including erythema, blistering, and pigmentary changes. It has a range of efficacies depending on the protocol used with several different treatment protocols, including the induration protocol, the minimal erythema dose protocol, and the newer minimal blistering dose protocol. Although the excimer laser is not a first-line treatment, it remains an excellent treatment option for psoriasis patients and has been demonstrated to be an effective treatment with little to no side effects.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 22%
Student > Ph. D. Student 5 14%
Other 3 8%
Student > Doctoral Student 2 6%
Researcher 2 6%
Other 6 17%
Unknown 10 28%
Readers by discipline Count As %
Medicine and Dentistry 17 47%
Chemistry 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Social Sciences 1 3%
Other 3 8%
Unknown 11 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2023.
All research outputs
#3,622,544
of 25,584,565 outputs
Outputs from Psoriasis : Targets and Therapy
#26
of 79 outputs
Outputs of similar age
#66,194
of 417,676 outputs
Outputs of similar age from Psoriasis : Targets and Therapy
#2
of 3 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 79 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.2. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 417,676 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.